We Update you with the Clock Running. Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient's, Health Care staff, Explains Patient Family Education and Rights.
Savient Pharmaceuticals Completes Puricase Phase 3 Studies For Treatment-Failure Gout
Gout Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced the completion of the in-life portion of its two pivotal Phase 3 clinical trials for Puricase® (pegloticase) in patients with treatment-failure gout, an orphan indication. Puricase is a pegylated recombinant mammalian urate oxidase that is being developed to control hyperuricemia and its clinical consequences in patients for whom conventional therapy is contraindicated or has been ineffective. [click link for full article]
Custom Search
